Exact Mass: 361.2253

Exact Mass Matches: 361.2253

Found 415 metabolites which its exact mass value is equals to given mass value 361.2253, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Phalaenopsine T

Phalaenopsine Is

C20H27NO5 (361.1889)


   

PHA-793887

N-(6,6-dimethyl-5-(1-methylpiperidine-4-carbonyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)-3-methylbutanamide

C19H31N5O2 (361.2478)


   

N-Arachidonoylglycine

N-[(5Z,8Z,11Z,14Z)-1-oxo-5,8,11,14-Eicosatetraen-1-yl]glycine

C22H35NO3 (361.2617)


N-Arachidonoylglycine (NAGly) is an endogenous lipid, which is a metabolite of the endocannabinoid anandamide by oxidation and acts as an efficacious agonist at GPR18. A previous study demonstrates that NAGly triggers antinociceptive and anti-inflammatory activities. A human metabolite taken as a putative food compound of mammalian origin [HMDB]

   

4-Hydroxydecanedioylcarnitine

3-[(9-carboxy-4-hydroxynonanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO7 (361.21)


4-Hydroxydecanedioylcarnitine is an acylcarnitine. More specifically, it is an 4-hydroxydecanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Hydroxydecanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Hydroxydecanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Hydroxydecanedioylcarnitine

3-[(9-carboxy-3-hydroxynonanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO7 (361.21)


3-Hydroxydecanedioylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxydecanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Hydroxydecanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-Hydroxydecanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Hydroxydecanedioylcarnitine

3-[(9-carboxy-5-hydroxynonanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO7 (361.21)


5-Hydroxydecanedioylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxydecanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Hydroxydecanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Hydroxydecanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

N-Arachidonoyl Glycine

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-{4-[(1-hydroxyethylidene)amino]-2-methoxyphenoxy}oxane-2-carboxylic acid

C22H35NO3 (361.2617)


N-arachidonoyl glycine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Glycine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Glycine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Glycine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules. A human metabolite taken as a putative food compound of mammalian origin [HMDB]

   

(+)-Butaclamol

3-Tert-butyl-2,3,4,4a,8,9,13b,14-octahydro-1h-benzo[6,7]cyclohepta[1,2,3-de]pyrido[2,1-a]isoquinolin-3-ol

C25H31NO (361.2406)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants

   

6-(6-(3r-Hydroxy-1e,5z-undecadien-1-yl)-2-pyridinyl)-1,5s-hexanediol

6-(6-(3r-Hydroxy-1e,5z-undecadien-1-yl)-2-pyridinyl)-1,5s-hexanediol

C22H35NO3 (361.2617)


   

Carbocromen

Ethyl 2-({3-[2-(diethylamino)ethyl]-4-methyl-2-oxo-2H-chromen-7-yl}oxy)acetic acid

C20H27NO5 (361.1889)


C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Octocrylene

2-Ethylhexyl 2-cyano-3,3-diphenylprop-2-enoic acid

C24H27NO2 (361.2042)


C1892 - Chemopreventive Agent > C851 - Sunscreen

   

rac S 33138

N-[4-(2-{12-cyano-8-oxa-4-azatricyclo[7.4.0.0^{2,6}]trideca-1(9),10,12-trien-4-yl}ethyl)phenyl]acetamide

C22H23N3O2 (361.179)


   

Semagacestat

2-Hydroxy-3-methyl-N-{1-[(3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-3-benzazepin-1-yl)-C-hydroxycarbonimidoyl]ethyl}butanimidate

C19H27N3O4 (361.2001)


   
   

Leucylnegamycin

(S)-L-threo-Hexonic acid

C15H31N5O5 (361.2325)


   

(+)-Kobutimycin B

(+)-Kobutimycin B

C20H27NO5 (361.1889)


   

Broussonetine F

Broussonetine F

C18H35NO6 (361.2464)


   

Broussonetine E

Broussonetine E

C18H35NO6 (361.2464)


   

Epihernandolinol

Epihernandolinol

C20H27NO5 (361.1889)


   

Dihydroajaconine

7,24-Secoajaconine

C22H35NO3 (361.2617)


   
   

Tricalysiamide C

Tricalysiamide C

C21H31NO4 (361.2253)


   

Leuconicine A

Leuconicine A

C22H23N3O2 (361.179)


   

Bacithrocin C 2

Bacithrocin C 2

C18H27N5O3 (361.2114)


   
   

Robustamine cis-N-oxide

Robustamine cis-N-oxide

C20H27NO5 (361.1889)


   

Consorientaline

Consorientaline

C22H35NO3 (361.2617)


   

Daphnezomine A

Daphnezomine A

C22H35NO3 (361.2617)


   

Daphodhamine B

Daphodhamine B

C22H35NO3 (361.2617)


   

Octocrylene

Octocrylene

C24H27NO2 (361.2042)


C1892 - Chemopreventive Agent > C851 - Sunscreen CONFIDENCE standard compound; INTERNAL_ID 2501 CONFIDENCE standard compound; INTERNAL_ID 8141 CONFIDENCE standard compound; EAWAG_UCHEM_ID 229

   

N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentan-1-yl)-1H-indole-3-carboxamide

N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentan-1-yl)-1H-indole-3-carboxamide

C20H28FN3O2 (361.2165)


   

Murrayamine F

Murrayamine F

C24H27NO2 (361.2042)


   

(Z)-N-<2-(4-hydroxy-3-methoxyphenyl)ethyl>-3-methyldodec-2-enamide|(Z)-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-methyldodec-2-enamide|3-Methoxy-(Z)-N-[2-(4-Hydroxyphenyl)-ethyl]-3-methyl-2-dodecenamide

(Z)-N-<2-(4-hydroxy-3-methoxyphenyl)ethyl>-3-methyldodec-2-enamide|(Z)-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-methyldodec-2-enamide|3-Methoxy-(Z)-N-[2-(4-Hydroxyphenyl)-ethyl]-3-methyl-2-dodecenamide

C22H35NO3 (361.2617)


   

17-Hydroxyhomodaphniphyllic acid

17-Hydroxyhomodaphniphyllic acid

C22H35NO3 (361.2617)


   

beta-Methoxy-Mahanimbicine|Murrayamine-C

beta-Methoxy-Mahanimbicine|Murrayamine-C

C24H27NO2 (361.2042)


   

Ditryptophenaline

Ditryptophenaline

C22H23N3O2 (361.179)


   

Murrayamine H

Murrayamine H

C24H27NO2 (361.2042)


   

(Z)-N-<2-(3-hydroxy-4-methoxyphenyl)ethyl>-3-methyldodec-2-enamide|(Z)-N-[2-(3-hydroxy-4-methoxyphenyl)ethyl]-3-methyldodec-2-enamide|Me ether,3-hydroxy-(Z)-N-[2-(4-Hydroxyphenyl)-ethyl]-3-methyl-2-dodecenamide

(Z)-N-<2-(3-hydroxy-4-methoxyphenyl)ethyl>-3-methyldodec-2-enamide|(Z)-N-[2-(3-hydroxy-4-methoxyphenyl)ethyl]-3-methyldodec-2-enamide|Me ether,3-hydroxy-(Z)-N-[2-(4-Hydroxyphenyl)-ethyl]-3-methyl-2-dodecenamide

C22H35NO3 (361.2617)


   
   
   

septentriosine

septentriosine

C20H27NO5 (361.1889)


   

Murrayamine B

Murrayamine B

C24H27NO2 (361.2042)


   

de-N-methylicaceine

de-N-methylicaceine

C21H31NO4 (361.2253)


   

20-ethyl-1alpha,8-dihydroxy-4-methyl-heteratisan-14-one|Hetereophyllin|heterophylline|heterophylline (Aconitum)

20-ethyl-1alpha,8-dihydroxy-4-methyl-heteratisan-14-one|Hetereophyllin|heterophylline|heterophylline (Aconitum)

C21H31NO4 (361.2253)


   

1alphaH,5alphaH,6betaH,7alphaH,11betaH-3beta-hydroxy-11alpha-[(tetrahydro-5-oxo-furan-2-yl)methylamino]methylguaia-4(15),10(14)-dien-12,6-olide|scorzoaustriacin

1alphaH,5alphaH,6betaH,7alphaH,11betaH-3beta-hydroxy-11alpha-[(tetrahydro-5-oxo-furan-2-yl)methylamino]methylguaia-4(15),10(14)-dien-12,6-olide|scorzoaustriacin

C20H27NO5 (361.1889)


   

Cephalofortuneine

Cephalofortuneine

C20H27NO5 (361.1889)


   

methyl (2R,5S,8S,15R)-5-ethyl-6-hydroxy-2-hydroxymethyl-6-azapentacyclo[9.5.1.01,5.02,8.014,17]heptadec-11(17)-ene-15-carboxylate|N-hydroxypaxdaphnine B

methyl (2R,5S,8S,15R)-5-ethyl-6-hydroxy-2-hydroxymethyl-6-azapentacyclo[9.5.1.01,5.02,8.014,17]heptadec-11(17)-ene-15-carboxylate|N-hydroxypaxdaphnine B

C21H31NO4 (361.2253)


   
   

2alpha-methoxy-6-O-methyllycorenine

2alpha-methoxy-6-O-methyllycorenine

C20H27NO5 (361.1889)


   

7-methoxy-O-methyllycorenine

7-methoxy-O-methyllycorenine

C20H27NO5 (361.1889)


   

Liconosine A|N-deethyl-N,19-didehydrosachaconitine|N-deethyl-N-19-didehydrosachaconitine

Liconosine A|N-deethyl-N,19-didehydrosachaconitine|N-deethyl-N-19-didehydrosachaconitine

C21H31NO4 (361.2253)


   

eremolactam B

eremolactam B

C21H31NO4 (361.2253)


   

diacetyl obscuraminol A

diacetyl obscuraminol A

C22H35NO3 (361.2617)


   

O-Methylmahanine

O-Methylmahanine

C24H27NO2 (361.2042)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

glutaminylseryllysine

glutaminylseryllysine

C14H27N5O6 (361.1961)


   
   
   
   
   
   

seryllysyllysine

seryllysyllysine

C15H31N5O5 (361.2325)


   

asparagylthreonyllysine

asparagylthreonyllysine

C14H27N5O6 (361.1961)


   
   
   
   
   
   
   
   
   
   
   
   

threonylasparagyllysine

threonylasparagyllysine

C14H27N5O6 (361.1961)


   
   
   
   
   
   
   
   

Ala Gly Lys Ser

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-aminopropanamido]acetamido}hexanamido]-3-hydroxypropanoic acid

C14H27N5O6 (361.1961)


   

Ala Gly Ser Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-hydroxypropanamido]hexanoic acid

C14H27N5O6 (361.1961)


   

Ala Lys Gly Ser

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]acetamido}-3-hydroxypropanoic acid

C14H27N5O6 (361.1961)


   

Ala Lys Ser Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-hydroxypropanamido]acetic acid

C14H27N5O6 (361.1961)


   

Ala Ser Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]acetamido}hexanoic acid

C14H27N5O6 (361.1961)


   

Ala Ser Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]hexanamido]acetic acid

C14H27N5O6 (361.1961)


   

Gly Ala Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)propanamido]hexanamido]-3-hydroxypropanoic acid

C14H27N5O6 (361.1961)


   

Gly Ala Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-hydroxypropanamido]hexanoic acid

C14H27N5O6 (361.1961)


   

Gly Gly Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[2-(2-aminoacetamido)acetamido]hexanamido]-3-hydroxybutanoic acid

C14H27N5O6 (361.1961)


   

Gly Gly Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[2-(2-aminoacetamido)acetamido]-3-hydroxybutanamido]hexanoic acid

C14H27N5O6 (361.1961)


   

Gly Lys Ala Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]propanamido]-3-hydroxypropanoic acid

C14H27N5O6 (361.1961)


   

Gly Lys Gly Thr

(2S,3R)-2-{2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]acetamido}-3-hydroxybutanoic acid

C14H27N5O6 (361.1961)


   

Gly Lys Ser Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-hydroxypropanamido]propanoic acid

C14H27N5O6 (361.1961)


   

Gly Lys Thr Gly

2-[(2S,3R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-hydroxybutanamido]acetic acid

C14H27N5O6 (361.1961)


   

Gly Ser Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]propanamido]hexanoic acid

C14H27N5O6 (361.1961)


   

Gly Ser Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]hexanamido]propanoic acid

C14H27N5O6 (361.1961)


   

Gly Thr Gly Lys

(2S)-6-amino-2-{2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]acetamido}hexanoic acid

C14H27N5O6 (361.1961)


   

Gly Thr Lys Gly

2-[(2S)-6-amino-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]hexanamido]acetic acid

C14H27N5O6 (361.1961)


   
   
   

Lys Ala Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]acetamido}-3-hydroxypropanoic acid

C14H27N5O6 (361.1961)


   

Lys Ala Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-hydroxypropanamido]acetic acid

C14H27N5O6 (361.1961)


   

Lys Gly Ala Ser

(2S)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}propanamido]-3-hydroxypropanoic acid

C14H27N5O6 (361.1961)


   

Lys Gly Gly Thr

(2S,3R)-2-(2-{2-[(2S)-2,6-diaminohexanamido]acetamido}acetamido)-3-hydroxybutanoic acid

C14H27N5O6 (361.1961)


   

Lys Gly Ser Ala

(2S)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-hydroxypropanamido]propanoic acid

C14H27N5O6 (361.1961)


   

Lys Gly Thr Gly

2-[(2S,3R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-hydroxybutanamido]acetic acid

C14H27N5O6 (361.1961)


   

Lys Ser Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]propanamido]acetic acid

C14H27N5O6 (361.1961)


   

Lys Ser Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]acetamido}propanoic acid

C14H27N5O6 (361.1961)


   

Lys Thr Gly Gly

2-{2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]acetamido}acetic acid

C14H27N5O6 (361.1961)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Ser Ala Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]acetamido}hexanoic acid

C14H27N5O6 (361.1961)


   

Ser Ala Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]hexanamido]acetic acid

C14H27N5O6 (361.1961)


   
   

Ser Gly Ala Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}propanamido]hexanoic acid

C14H27N5O6 (361.1961)


   

Ser Gly Lys Ala

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}hexanamido]propanoic acid

C14H27N5O6 (361.1961)


   
   

Ser Lys Ala Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]propanamido]acetic acid

C14H27N5O6 (361.1961)


   

Ser Lys Gly Ala

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]acetamido}propanoic acid

C14H27N5O6 (361.1961)


   
   

Thr Gly Gly Lys

(2S)-6-amino-2-(2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}acetamido)hexanoic acid

C14H27N5O6 (361.1961)


   

Thr Gly Lys Gly

2-[(2S)-6-amino-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}hexanamido]acetic acid

C14H27N5O6 (361.1961)


   

Thr Lys Gly Gly

2-{2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]acetamido}acetic acid

C14H27N5O6 (361.1961)


   

NAGly

N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycine

C22H35NO3 (361.2617)


   

U-75302

6-(6-(3r-Hydroxy-1e,5z-undecadien-1-yl)-2-pyridinyl)-1,5s-hexanediol

C22H35NO3 (361.2617)


   

NA 22:5;O2

N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycine

C22H35NO3 (361.2617)


   

EEQ-EA

N-(17(18)-epoxy-5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine

C22H35NO3 (361.2617)


   

anti-testosterone-3-CMO

2-[(E)-[(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetic acid

C21H31NO4 (361.2253)


   
   

Cinchonan-9-amine, 10,11-dihydro-6-methoxy-, trihydrochloride , (9R)

Cinchonan-9-amine, 10,11-dihydro-6-methoxy-, trihydrochloride , (9R)

C20H28ClN3O (361.1921)


   

Levophenacylmorphan

Levophenacylmorphan

C24H27NO2 (361.2042)


   
   

Butaclamol

(+)-BUTACLAMOL

C25H31NO (361.2406)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants

   

2-amino-1,9-dihydro-9-methyl-6H-purin-6-one

2-amino-1,9-dihydro-9-methyl-6H-purin-6-one

C24H31N3 (361.2518)


   

6-(4-(Ethoxycarbonyl)piperazin-1-yl)pyridine-3-boronic acid pinacol ester

6-(4-(Ethoxycarbonyl)piperazin-1-yl)pyridine-3-boronic acid pinacol ester

C18H28BN3O4 (361.2173)


   

3-Pyridinemethanol, 4-(4-fluoro-2-hydroxyphenyl)-a-methyl-2,6-bis(1-methylethyl)-5-propyl-

3-Pyridinemethanol, 4-(4-fluoro-2-hydroxyphenyl)-a-methyl-2,6-bis(1-methylethyl)-5-propyl-

C22H32FNO2 (361.2417)


   

2-Bromo-N-hexadecylacetamide

2-Bromo-N-hexadecylacetamide

C18H36BrNO (361.198)


   

3-Pyridinemethanol, 4-(4-fluoro-2-hydroxyphenyl)-a-methyl-2,6-bis(1-methylethyl)-5-propyl-, (aR,4R)- (9CI)

3-Pyridinemethanol, 4-(4-fluoro-2-hydroxyphenyl)-a-methyl-2,6-bis(1-methylethyl)-5-propyl-, (aR,4R)- (9CI)

C22H32FNO2 (361.2417)


   

(+/-)-butaclamol hcl

(+/-)-butaclamol hcl

C25H31NO (361.2406)


   

methyl 5-[tert-butyl(dimethyl)silyl]oxy-4-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate

methyl 5-[tert-butyl(dimethyl)silyl]oxy-4-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate

C17H35NO5Si (361.2284)


   

1-(Piperidin-1-yl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propan-2-ol

1-(Piperidin-1-yl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propan-2-ol

C20H32BNO4 (361.2424)


   
   

4-Cyanophenyl trans-4-(4-butylcyclohexyl)benzoate

4-Cyanophenyl trans-4-(4-butylcyclohexyl)benzoate

C24H27NO2 (361.2042)


   

3,3-diphenyl-N-(3-phenylsulfanylpropyl)propan-1-amine

3,3-diphenyl-N-(3-phenylsulfanylpropyl)propan-1-amine

C24H27NS (361.1864)


   

BENZYL N-BOC-4-ISOPROPYL-4-PIPERIDINECARBOXYLATE

BENZYL N-BOC-4-ISOPROPYL-4-PIPERIDINECARBOXYLATE

C21H31NO4 (361.2253)


   

N-([1,1-biphenyl]-4-yl)-9,9-dimethyl-9H-fluoren-2-amine

N-([1,1-biphenyl]-4-yl)-9,9-dimethyl-9H-fluoren-2-amine

C27H23N (361.183)


   

1,3-Propanediamine,N1,N1-diethyl-N3-(6-methyl-5H-pyrido[3,4:4,5]pyrrolo[2,3-g]isoquinolin-10-yl)-

1,3-Propanediamine,N1,N1-diethyl-N3-(6-methyl-5H-pyrido[3,4:4,5]pyrrolo[2,3-g]isoquinolin-10-yl)-

C22H27N5 (361.2266)


   

butyl prop-2-enoate,N-(methoxymethyl)-2-methylprop-2-enamide,styrene

butyl prop-2-enoate,N-(methoxymethyl)-2-methylprop-2-enamide,styrene

C21H31NO4 (361.2253)


   

tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazine-4(3H)-carboxylate

tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazine-4(3H)-carboxylate

C19H28BNO5 (361.206)


   

(2R)-2-[(4-tert-butylphenyl)methyl]-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid

(2R)-2-[(4-tert-butylphenyl)methyl]-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid

C21H31NO4 (361.2253)


   

Semagacestat

Semagacestat(LY450139)

C19H27N3O4 (361.2001)


D004791 - Enzyme Inhibitors > D000091062 - Gamma Secretase Inhibitors and Modulators C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

1-TRIISOPROPYLSILANYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXYLIC ACID METHOXY-METHYL-AMIDE

1-TRIISOPROPYLSILANYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXYLIC ACID METHOXY-METHYL-AMIDE

C19H31N3O2Si (361.2185)


   

N-[1,1-Biphenyl]-4-yl-9,9-dimethyl-9H-fluoren-3-amine

N-[1,1-Biphenyl]-4-yl-9,9-dimethyl-9H-fluoren-3-amine

C27H23N (361.183)


   

Furethidine

ethyl 1-[2-(oxolan-2-ylmethoxy)ethyl]-4-phenylpiperidine-4-carboxylate

C21H31NO4 (361.2253)


C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist

   

N-[1,1-Biphenyl]-2-yl-9,9-dimethyl-9H-fluoren-2-amine

N-[1,1-Biphenyl]-2-yl-9,9-dimethyl-9H-fluoren-2-amine

C27H23N (361.183)


   

Tert-Butyl(S)-1-((S)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[d]azepin-1-ylamino)-1-oxopropan-2-ylcarbamate

Tert-Butyl(S)-1-((S)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[d]azepin-1-ylamino)-1-oxopropan-2-ylcarbamate

C19H27N3O4 (361.2001)


   

2-(diethylamino)ethyl 2,2-diphenylpropanoate,hydrochloride

2-(diethylamino)ethyl 2,2-diphenylpropanoate,hydrochloride

C21H28ClNO2 (361.1808)


   

4-((4-(DIETHYLAMINO)PHENYL)IMINO)-N-METHYL-1-OXO-1,4-DIHYDRONAPHTHALENE-2-CARBOXAMIDE

4-((4-(DIETHYLAMINO)PHENYL)IMINO)-N-METHYL-1-OXO-1,4-DIHYDRONAPHTHALENE-2-CARBOXAMIDE

C22H23N3O2 (361.179)


   

2,3,4,5-Tetrahydro-2-isobutyl-8-methyl-5-[2-(6-methyl-3-pyridyl)ethyl]-1H-pyrido[4,3-b]indole

2,3,4,5-Tetrahydro-2-isobutyl-8-methyl-5-[2-(6-methyl-3-pyridyl)ethyl]-1H-pyrido[4,3-b]indole

C24H31N3 (361.2518)


   

BOC-(S)-ALPHA-(4-TERT-BUTYL-BENZYL)-PROLINE

BOC-(S)-ALPHA-(4-TERT-BUTYL-BENZYL)-PROLINE

C21H31NO4 (361.2253)


   

3-(2-Methoxy-5-methylphenyl)-3-phenylpropanol

3-(2-Methoxy-5-methylphenyl)-3-phenylpropanol

C22H32ClNO (361.2172)


   

1-Butanol, 4-[(5,6-diphenyl-2-pyrazinyl)(1-methylethyl)amino]-

1-Butanol, 4-[(5,6-diphenyl-2-pyrazinyl)(1-methylethyl)amino]-

C23H27N3O (361.2154)


   

4-(Triethoxysilylpropoxy)-2,2,6,6-Tetramethylpiperidine

4-(Triethoxysilylpropoxy)-2,2,6,6-Tetramethylpiperidine

C18H39NO4Si (361.2648)


   

N-cyclohexyl-2-(4-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)phenoxy)acetamide

N-cyclohexyl-2-(4-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)phenoxy)acetamide

C21H31NO4 (361.2253)


   

N-Butadecanoyl-D-phenylglycine

N-Butadecanoyl-D-phenylglycine

C22H35NO3 (361.2617)


   

5,7-dihydro-7,7-diMethyl-5-phenyl-indeno[2,1-b]carbazole

5,7-dihydro-7,7-diMethyl-5-phenyl-indeno[2,1-b]carbazole

C27H23N (361.183)


   

N-Butadecanoyl-L-phenylglycine

N-Butadecanoyl-L-phenylglycine

C22H35NO3 (361.2617)


   

Dapiprazole Hydrochloride

Dapiprazole Hydrochloride

C19H28ClN5 (361.2033)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants Dapiprazole hydrochloride is a potent, selective and orally active alpha-1 adrenoceptor antagonist. Dapiprazole hydrochloride suppresses the opioid withdrawal symptoms. Dapiprazole hydrochloride is also used as eye drops for reversing mydriasis[1][2][3].

   

Decyl 2-acetamido-2-deoxy-β-D-glucopyranoside

Decyl 2-acetamido-2-deoxy-β-D-glucopyranoside

C18H35NO6 (361.2464)


   

2-(1-(tert-Butoxycarbonyl)spiro[chroman-2,4-piperidine]-4-yl)acetic acid

2-(1-(tert-Butoxycarbonyl)spiro[chroman-2,4-piperidine]-4-yl)acetic acid

C20H27NO5 (361.1889)


   

2-[acetyl-[3-(diethylamino)propyl]amino]-N-(2,4,6-trimethylphenyl)propanamide

2-[acetyl-[3-(diethylamino)propyl]amino]-N-(2,4,6-trimethylphenyl)propanamide

C21H35N3O2 (361.2729)


   

buquinolate

buquinolate

C20H27NO5 (361.1889)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

   

Bradanicline

Bradanicline

C22H23N3O2 (361.179)


C78272 - Agent Affecting Nervous System Bradanicline is a highly selective α7 nicotinic acetylcholine receptor (nAChR) agonist (humanα7 nAChR: EC50=17 nM; Ki= 1.4 nM). Bradanicline is used for the research of cognitive disorders[1][2].

   

Prenoxdiazine

Prenoxdiazine

C23H27N3O (361.2154)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent

   

1-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl]-3-[(2S)-1-(thiophen-3-yl)propan-2-yl]urea

1-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl]-3-[(2S)-1-(thiophen-3-yl)propan-2-yl]urea

C19H27N3O2S (361.1824)


PZM21 is a potent and selective μ opioid receptor agonist with an EC50 of 1.8 nM[1][2][3].

   

Etafenone hydrochloride

Etafenone hydrochloride

C21H28ClNO2 (361.1808)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Butaclamol free base

Butaclamol free base

C25H31NO (361.2406)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

   

2-[(4-phenyl-1-piperazinyl)methyl]-3,6-dihydro-2H-imidazo[1,2-c]quinazolin-5-one

2-[(4-phenyl-1-piperazinyl)methyl]-3,6-dihydro-2H-imidazo[1,2-c]quinazolin-5-one

C21H23N5O (361.1903)


   

N-(1-adamantyl)-4-[oxo(2-oxolanyl)methyl]-1-piperazinecarboxamide

N-(1-adamantyl)-4-[oxo(2-oxolanyl)methyl]-1-piperazinecarboxamide

C20H31N3O3 (361.2365)


   

L-Seryl-L-lysyl-L-lysine

L-Seryl-L-lysyl-L-lysine

C15H31N5O5 (361.2325)


   

Pharmakon1600-01506187

Pharmakon1600-01506187

C24H27NO2 (361.2042)


   

17-(4-Hydroxyphenyl)heptadecanoate

17-(4-Hydroxyphenyl)heptadecanoate

C23H37O3- (361.2743)


   

(6R)-3,5,6-trihydroxy-2-(3-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)cyclo

(6R)-3,5,6-trihydroxy-2-(3-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)cyclo

C21H29O5- (361.2015)


   

(4R)-4,5-dihydroxy-2-(2-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)-3-oxocyclohexa-1,5-dien-1-olate

(4R)-4,5-dihydroxy-2-(2-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)-3-oxocyclohexa-1,5-dien-1-olate

C21H29O5- (361.2015)


   
   
   

4-Hydroxydecanedioylcarnitine

4-Hydroxydecanedioylcarnitine

C17H31NO7 (361.21)


   

3-Hydroxydecanedioylcarnitine

3-Hydroxydecanedioylcarnitine

C17H31NO7 (361.21)


   

5-Hydroxydecanedioylcarnitine

5-Hydroxydecanedioylcarnitine

C17H31NO7 (361.21)


   

(2S)-6-amino-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-hydroxypropanoyl]amino]hexanoic acid

(2S)-6-amino-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-hydroxypropanoyl]amino]hexanoic acid

C15H31N5O5 (361.2325)


   

11-[2-(Diethylamino)ethylamino]-7,8,9,10-tetrahydrobenzimidazolo[1,2-b]isoquinoline-6-carbonitrile

11-[2-(Diethylamino)ethylamino]-7,8,9,10-tetrahydrobenzimidazolo[1,2-b]isoquinoline-6-carbonitrile

C22H27N5 (361.2266)


   

4-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-1H-quinolin-2-one

4-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-1H-quinolin-2-one

C22H23N3O2 (361.179)


   

3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)propanamide

3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)propanamide

C22H23N3O2 (361.179)


   

1-[1-(Phenylmethyl)-4-piperidinyl]-3-(2,4,4-trimethylpentan-2-yl)thiourea

1-[1-(Phenylmethyl)-4-piperidinyl]-3-(2,4,4-trimethylpentan-2-yl)thiourea

C21H35N3S (361.2552)


   

1-[4-(2,3-Dimethylphenyl)-1-piperazinyl]-2-(1-methyl-3-indolyl)ethanone

1-[4-(2,3-Dimethylphenyl)-1-piperazinyl]-2-(1-methyl-3-indolyl)ethanone

C23H27N3O (361.2154)


   

(4Z,7Z,10Z,13Z,15E,17S)-17-hydroperoxydocosa-4,7,10,13,15-pentaenoate

(4Z,7Z,10Z,13Z,15E,17S)-17-hydroperoxydocosa-4,7,10,13,15-pentaenoate

C22H33O4- (361.2379)


   

(7Z,10Z,13Z,15E,19Z)-17-hydroperoxydocosa-7,10,13,15,19-pentaenoate

(7Z,10Z,13Z,15E,19Z)-17-hydroperoxydocosa-7,10,13,15,19-pentaenoate

C22H33O4- (361.2379)


   

(7Z,10Z,12E,16Z,19Z)-14-hydroperoxydocosa-7,10,12,16,19-pentaenoate

(7Z,10Z,12E,16Z,19Z)-14-hydroperoxydocosa-7,10,12,16,19-pentaenoate

C22H33O4- (361.2379)


   

(4Z,7Z,10Z,12E,16Z)-14-hydroperoxydocosa-4,7,10,12,16-pentaenoate

(4Z,7Z,10Z,12E,16Z)-14-hydroperoxydocosa-4,7,10,12,16-pentaenoate

C22H33O4- (361.2379)


   
   
   
   
   
   
   
   
   

(8E,10Z,14E,16Z,19Z)-7,13-dihydroxydocosa-8,10,14,16,19-pentaenoate

(8E,10Z,14E,16Z,19Z)-7,13-dihydroxydocosa-8,10,14,16,19-pentaenoate

C22H33O4- (361.2379)


   

2-[[(5E,8E,11E,14E)-Icosa-5,8,11,14-tetraenoyl]amino]acetic acid

2-[[(5E,8E,11E,14E)-Icosa-5,8,11,14-tetraenoyl]amino]acetic acid

C22H35NO3 (361.2617)


   

2-(dimethylamino)-1-[(1S,5R)-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]ethanone

2-(dimethylamino)-1-[(1S,5R)-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]ethanone

C23H27N3O (361.2154)


   

N-[[(2R,3S,4R)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)-N-propan-2-ylacetamide

N-[[(2R,3S,4R)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)-N-propan-2-ylacetamide

C20H31N3O3 (361.2365)


   

N-[[(2R,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

N-[[(2R,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

C19H27N3O4 (361.2001)


   

N-[[(2R,3S,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

N-[[(2R,3S,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

C19H27N3O4 (361.2001)


   

4-[(3aR,4S,9bS)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

4-[(3aR,4S,9bS)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

C22H23N3O2 (361.179)


   

N-[[(2S,3R,4S)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)-N-propan-2-ylacetamide

N-[[(2S,3R,4S)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)-N-propan-2-ylacetamide

C20H31N3O3 (361.2365)


   

[(2R,3S,4S)-1-(4-ethyl-2-thiazolyl)-4-[(2-methoxyethylamino)methyl]-3-phenyl-2-azetidinyl]methanol

[(2R,3S,4S)-1-(4-ethyl-2-thiazolyl)-4-[(2-methoxyethylamino)methyl]-3-phenyl-2-azetidinyl]methanol

C19H27N3O2S (361.1824)


   

N-[[(2R,3R,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

N-[[(2R,3R,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

C19H27N3O4 (361.2001)


   

N-[[(2S,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

N-[[(2S,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

C19H27N3O4 (361.2001)


   

N-[[(2R,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

N-[[(2R,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

C19H27N3O4 (361.2001)


   

N-[[(2S,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

N-[[(2S,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

C19H27N3O4 (361.2001)


   

4-[(3aS,4R,9bR)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

4-[(3aS,4R,9bR)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

C22H23N3O2 (361.179)


   

4-[(3aR,4R,9bS)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

4-[(3aR,4R,9bS)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

C22H23N3O2 (361.179)


   

4-[(3aS,4S,9bR)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

4-[(3aS,4S,9bR)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

C22H23N3O2 (361.179)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(7Z,9E,11E,14S,16Z,19Z)-13,14-dihydroxydocosa-7,9,11,16,19-pentaenoate

(7Z,9E,11E,14S,16Z,19Z)-13,14-dihydroxydocosa-7,9,11,16,19-pentaenoate

C22H33O4- (361.2379)


   

(7Z,10Z,12E,14S,16Z,19Z)-14,21-dihydroxydocosa-7,10,12,16,19-pentaenoate

(7Z,10Z,12E,14S,16Z,19Z)-14,21-dihydroxydocosa-7,10,12,16,19-pentaenoate

C22H33O4- (361.2379)


   

(7R,8E,10E,12Z,14S,16Z,19Z)-7,14-dihydroxydocosa-8,10,12,16,19-pentaenoate

(7R,8E,10E,12Z,14S,16Z,19Z)-7,14-dihydroxydocosa-8,10,12,16,19-pentaenoate

C22H33O4- (361.2379)


   

7,17-dihydroxy-(8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoate

7,17-dihydroxy-(8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoate

C22H33O4- (361.2379)


A docosanoid anion that is the conjugate base of 7,17-dihydroxy-(8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(7Z,10R,11E,13E,15Z,17S,19Z)-10,17-dihydroxydocosa-7,11,13,15,19-pentaenoate

(7Z,10R,11E,13E,15Z,17S,19Z)-10,17-dihydroxydocosa-7,11,13,15,19-pentaenoate

C22H33O4- (361.2379)


   

(7Z,10Z,12E,14E,17S,19Z)-16,17-dihydroxydocosa-7,10,12,14,19-pentaenoate

(7Z,10Z,12E,14E,17S,19Z)-16,17-dihydroxydocosa-7,10,12,14,19-pentaenoate

C22H33O4- (361.2379)


   

(3R,11R)-11-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxydodecanoate

(3R,11R)-11-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxydodecanoate

C18H33O7- (361.2226)


   

(3R)-12-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxydodecanoate

(3R)-12-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxydodecanoate

C18H33O7- (361.2226)


   

(7Z,10Z,12E,14S,16Z,19Z)-14-hydroperoxydocosa-7,10,12,16,19-pentaenoate

(7Z,10Z,12E,14S,16Z,19Z)-14-hydroperoxydocosa-7,10,12,16,19-pentaenoate

C22H33O4- (361.2379)


   

(7Z,10Z,13Z,15E,17S,19Z)-17-hydroperoxydocosa-7,10,13,15,19-pentaenoate

(7Z,10Z,13Z,15E,17S,19Z)-17-hydroperoxydocosa-7,10,13,15,19-pentaenoate

C22H33O4- (361.2379)


   
   

4-(2-Butanoyloxy-3-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(2-Butanoyloxy-3-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C17H31NO7 (361.21)


   

4-(3-Acetyloxy-2-pentanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(3-Acetyloxy-2-pentanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C17H31NO7 (361.21)


   

carbocromen

carbocromen

C20H27NO5 (361.1889)


C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

N-Arachidonylglycine

N-arachidonoylglycine

C22H35NO3 (361.2617)


Biologically active derivative of anandamide

   

resolvin T4(1-)

resolvin T4(1-)

C22H33O4 (361.2379)


A docosanoid anion that is the conjugate base of resolvin T4, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

14(S),21-dihydroxy-(7Z,10Z,12E,16Z,19Z)-docosapentaenoate

14(S),21-dihydroxy-(7Z,10Z,12E,16Z,19Z)-docosapentaenoate

C22H33O4 (361.2379)


A docosanoid anion that is the conjugate base of 14(S),21-dihydroxy-(7Z,10Z,12E,16Z,19Z)-docosapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(7R,14S)-dihydroxy-(8E,10E,12Z,16Z,19Z)-docosapentaenoate

(7R,14S)-dihydroxy-(8E,10E,12Z,16Z,19Z)-docosapentaenoate

C22H33O4 (361.2379)


A docosanoid anion that is the conjugate base of (7R,14S)-dihydroxy-(8E,10E,12Z,16Z,19Z)-docosapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(10R,17S)-dihydroxy-(7Z,11E,13E,15Z,19Z)-docosapentaenoate

(10R,17S)-dihydroxy-(7Z,11E,13E,15Z,19Z)-docosapentaenoate

C22H33O4 (361.2379)


A docosanoid anion that is the conjugate base of (10R,17S)-dihydroxy-(7Z,11E,13E,15Z,19Z)-docosapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

16,17(S)-dihydroxy-(7Z,10Z,13E,14E,19Z)-docosapentaenoate

16,17(S)-dihydroxy-(7Z,10Z,13E,14E,19Z)-docosapentaenoate

C22H33O4 (361.2379)


A docosanoid anion that is the conjugate base of 16,17(S)-dihydroxy-(7Z,10Z,13E,14E,19Z)-docosapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

bhas#20(1-)

bhas#20(1-)

C18H33O7 (361.2226)


Conjugate base of bhas#20

   

(7Z,10Z,12E,14S,16Z,19Z)-14-hydroperoxydocosapentaenoate

(7Z,10Z,12E,14S,16Z,19Z)-14-hydroperoxydocosapentaenoate

C22H33O4 (361.2379)


A (7Z,10Z,12E,16Z,19Z)-14-hydroperoxydocosapentaenoate in which the chiral centre at position 14 has S-configuration.

   

(7Z,10Z,13Z,15E,17S,19Z)-17-hydroperoxydocosapentaenoate

(7Z,10Z,13Z,15E,17S,19Z)-17-hydroperoxydocosapentaenoate

C22H33O4 (361.2379)


A (7Z,10Z,13Z,15E,19Z)-17-hydroperoxydocosapentaenoate in which the chiral centre at position 17 has S-configuration. An intermediate of specialised proresolving mediators.

   

13,14(S)-dihydroxy-(7Z,9E,11E,16Z,19Z)-docosapentaenoate

13,14(S)-dihydroxy-(7Z,9E,11E,16Z,19Z)-docosapentaenoate

C22H33O4 (361.2379)


A docosanoid anion that is the conjugate base of 13,14(S)-dihydroxy-(7Z,9E,11E,16Z,19Z)-docosapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

bhos#20(1-)

bhos#20(1-)

C18H33O7 (361.2226)


Conjugate base of bhos#20

   
   

NA-Dopamine 14:1(9Z)

NA-Dopamine 14:1(9Z)

C22H35NO3 (361.2617)


   

NA-Gly 20:4(5Z,8Z,11Z,14Z)

NA-Gly 20:4(5Z,8Z,11Z,14Z)

C22H35NO3 (361.2617)


   
   
   

NA-Taurine 16:1(9Z)

NA-Taurine 16:1(9Z)

C18H35NO4S (361.2287)


   
   
   

ST 18:3;O3;Gly

ST 18:3;O3;Gly

C20H27NO5 (361.1889)


   

ST 19:2;O2;Gly

ST 19:2;O2;Gly

C21H31NO4 (361.2253)


   

H-Ile-Pro-Pro-OH (hydrochloride)

H-Ile-Pro-Pro-OH (hydrochloride)

C16H28ClN3O4 (361.1768)


H-Ile-Pro-Pro-OH hydrochloride, a milk-derived peptide[1], inhibits angiotensin-converting enzyme (ACE)[1] with an IC50 of 5 μM[2]. Antihypertensive tripeptides[1].

   

SR59230A (hydrochloride)

SR59230A (hydrochloride)

C21H28ClNO2 (361.1808)


SR59230A hydrochloride is a potent, selective, and blood-brain barrier penetrating β3-adrenergic receptor antagonist[1] with IC50s of 40, 408, and 648 nM for β3, β1, and β2 receptors, respectively[2].

   

(13s)-13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,13-dihydroxytridecan-4-one

(13s)-13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,13-dihydroxytridecan-4-one

C18H35NO6 (361.2464)


   

(1r,2r,4r,5r,6s,7r,8r,9r,10r,13r,16s,17r)-11-ethyl-6,13-dimethyl-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecane-4,7,16-triol

(1r,2r,4r,5r,6s,7r,8r,9r,10r,13r,16s,17r)-11-ethyl-6,13-dimethyl-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecane-4,7,16-triol

C22H35NO3 (361.2617)


   

4-{6-hydroxy-14-isopropyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹²]hexadecan-2-yl}butanoic acid

4-{6-hydroxy-14-isopropyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹²]hexadecan-2-yl}butanoic acid

C22H35NO3 (361.2617)


   

13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecane-6,8-diol

13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecane-6,8-diol

C22H35NO3 (361.2617)


   

2-hydroxy-9a-methoxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,8ah,9h-cyclohexa[f]indol-6-yl 2-methylbut-2-enoate

2-hydroxy-9a-methoxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,8ah,9h-cyclohexa[f]indol-6-yl 2-methylbut-2-enoate

C21H31NO4 (361.2253)


   

(1s,2r,3r,4s,5s,8s,9s,10r,13r,16r,17r)-11-ethyl-16-methoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8-diol

(1s,2r,3r,4s,5s,8s,9s,10r,13r,16r,17r)-11-ethyl-16-methoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8-diol

C22H35NO3 (361.2617)


   

6-methoxy-13,16-dimethyl-19-(prop-1-en-2-yl)-15-oxa-4-azapentacyclo[14.3.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]icosa-2(14),3(11),5(10),6,8,12-hexaene

6-methoxy-13,16-dimethyl-19-(prop-1-en-2-yl)-15-oxa-4-azapentacyclo[14.3.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]icosa-2(14),3(11),5(10),6,8,12-hexaene

C24H27NO2 (361.2042)


   

4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene-13,16-diol

4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene-13,16-diol

C20H27NO5 (361.1889)


   

3-(acetyloxy)-1-[(10z)-8-methyl-2-oxa-6-azatricyclo[5.3.0.0¹,³]deca-6,8-dien-10-ylidene]butan-2-yl 2-methylbutanoate

3-(acetyloxy)-1-[(10z)-8-methyl-2-oxa-6-azatricyclo[5.3.0.0¹,³]deca-6,8-dien-10-ylidene]butan-2-yl 2-methylbutanoate

C20H27NO5 (361.1889)


   

(4as,5r,6s,8ar,9ar)-2-hydroxy-9a-methoxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,8ah,9h-cyclohexa[f]indol-6-yl (2z)-2-methylbut-2-enoate

(4as,5r,6s,8ar,9ar)-2-hydroxy-9a-methoxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,8ah,9h-cyclohexa[f]indol-6-yl (2z)-2-methylbut-2-enoate

C21H31NO4 (361.2253)


   

(1s,4s,9s,12s,13s,16r,17r)-17-(hydroxymethyl)-9-methoxy-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7-diene-7,17-diol

(1s,4s,9s,12s,13s,16r,17r)-17-(hydroxymethyl)-9-methoxy-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7-diene-7,17-diol

C21H31NO4 (361.2253)


   

(1r,4r,5r,13s,14s)-4-hydroxy-5,8-dimethoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),8,10(18)-trien-13-ium-13-olate

(1r,4r,5r,13s,14s)-4-hydroxy-5,8-dimethoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),8,10(18)-trien-13-ium-13-olate

C20H27NO5 (361.1889)


   

13-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,13-dihydroxytridecan-4-one

13-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,13-dihydroxytridecan-4-one

C18H35NO6 (361.2464)


   

(1r,2s,3s,5r,7s,10r,11s,13r,14r,17s,18s,19r)-4-ethyl-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosane-13,14,18-triol

(1r,2s,3s,5r,7s,10r,11s,13r,14r,17s,18s,19r)-4-ethyl-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosane-13,14,18-triol

C21H31NO4 (361.2253)


   

n-[3-(acetyloxy)octadeca-6,9,12,15-tetraen-2-yl]ethanimidic acid

n-[3-(acetyloxy)octadeca-6,9,12,15-tetraen-2-yl]ethanimidic acid

C22H35NO3 (361.2617)


   

(1s,4s,9s,12s,13r,16r,17r)-17-(hydroxymethyl)-9-methoxy-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7-diene-7,17-diol

(1s,4s,9s,12s,13r,16r,17r)-17-(hydroxymethyl)-9-methoxy-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7-diene-7,17-diol

C21H31NO4 (361.2253)


   

17-hydroxyhomodaphniphyllicacid

NA

C22H35NO3 (361.2617)


{"Ingredient_id": "HBIN002057","Ingredient_name": "17-hydroxyhomodaphniphyllicacid","Alias": "NA","Ingredient_formula": "C22H35NO3","Ingredient_Smile": "CC(C)C1CCC2(C3CCC45C(C2(C1N4C3)CCC(=O)O)CCC5O)C","Ingredient_weight": "361.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10165","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11152646","DrugBank_id": "NA"}

   

n-[(2s,3r,6z,9z,12z,15z)-3-(acetyloxy)octadeca-6,9,12,15-tetraen-2-yl]ethanimidic acid

n-[(2s,3r,6z,9z,12z,15z)-3-(acetyloxy)octadeca-6,9,12,15-tetraen-2-yl]ethanimidic acid

C22H35NO3 (361.2617)


   

6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-ene-4,8-diol

6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-ene-4,8-diol

C21H31NO4 (361.2253)


   

1-(1s,7ar)-hexahydro-1h-pyrrolizin-1-ylmethyl 4-methyl (2r)-2-benzyl-2-hydroxybutanedioate

1-(1s,7ar)-hexahydro-1h-pyrrolizin-1-ylmethyl 4-methyl (2r)-2-benzyl-2-hydroxybutanedioate

C20H27NO5 (361.1889)


   

n-{5-[(2r,3s,4e,6z)-2,8-dihydroxy-7-[(1z)-prop-1-en-1-yl]octa-4,6-dien-3-yl]-4-hydroxy-2-methoxyphenyl}ethanimidic acid

n-{5-[(2r,3s,4e,6z)-2,8-dihydroxy-7-[(1z)-prop-1-en-1-yl]octa-4,6-dien-3-yl]-4-hydroxy-2-methoxyphenyl}ethanimidic acid

C20H27NO5 (361.1889)


   

(13r)-13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,13-dihydroxytridecan-4-one

(13r)-13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,13-dihydroxytridecan-4-one

C18H35NO6 (361.2464)


   

2,2,2-trifluoro-1-(2-methyl-3-tridecyl-4,5-dihydropyrrol-1-yl)ethanone

2,2,2-trifluoro-1-(2-methyl-3-tridecyl-4,5-dihydropyrrol-1-yl)ethanone

C20H34F3NO (361.2592)


   

methyl (1r,2r,5s,8s,14r,15r)-5-ethyl-6-hydroxy-2-(hydroxymethyl)-6-azapentacyclo[9.5.1.0¹,⁵.0²,⁸.0¹⁴,¹⁷]heptadec-11(17)-ene-15-carboxylate

methyl (1r,2r,5s,8s,14r,15r)-5-ethyl-6-hydroxy-2-(hydroxymethyl)-6-azapentacyclo[9.5.1.0¹,⁵.0²,⁸.0¹⁴,¹⁷]heptadec-11(17)-ene-15-carboxylate

C21H31NO4 (361.2253)


   

(1s,2s,5s,8s,9s,10s,11r,15s,18r)-9,10,15,18-tetrahydroxy-12,12-dimethyl-6-methylidene-17-azapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadec-16-en-7-one

(1s,2s,5s,8s,9s,10s,11r,15s,18r)-9,10,15,18-tetrahydroxy-12,12-dimethyl-6-methylidene-17-azapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadec-16-en-7-one

C20H27NO5 (361.1889)


   

(1r,4r,5r,14s)-4-hydroxy-5,8-dimethoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),8,10(18)-trien-13-ium-13-olate

(1r,4r,5r,14s)-4-hydroxy-5,8-dimethoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),8,10(18)-trien-13-ium-13-olate

C20H27NO5 (361.1889)


   

4-[(1s,2s,3s,6r,7r,10s,13s,14r)-6-hydroxy-14-isopropyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹²]hexadecan-2-yl]butanoic acid

4-[(1s,2s,3s,6r,7r,10s,13s,14r)-6-hydroxy-14-isopropyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹²]hexadecan-2-yl]butanoic acid

C22H35NO3 (361.2617)


   

9-methoxy-3,8-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

9-methoxy-3,8-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

C24H27NO2 (361.2042)


   

9-methoxy-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

9-methoxy-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

C24H27NO2 (361.2042)


   

3-(acetyloxy)-1-{8-methyl-2-oxa-6-azatricyclo[5.3.0.0¹,³]deca-6,8-dien-10-ylidene}butan-2-yl 2-methylbutanoate

3-(acetyloxy)-1-{8-methyl-2-oxa-6-azatricyclo[5.3.0.0¹,³]deca-6,8-dien-10-ylidene}butan-2-yl 2-methylbutanoate

C20H27NO5 (361.1889)


   

n-{5-[(2z,4s,5e,7r)-1,7-dihydroxy-2-[(1z)-prop-1-en-1-yl]octa-2,5-dien-4-yl]-4-hydroxy-2-methoxyphenyl}ethanimidic acid

n-{5-[(2z,4s,5e,7r)-1,7-dihydroxy-2-[(1z)-prop-1-en-1-yl]octa-2,5-dien-4-yl]-4-hydroxy-2-methoxyphenyl}ethanimidic acid

C20H27NO5 (361.1889)


   

(1s,2r,3r,4s,5s,6s,8s,9s,10r,13r,16s,17r)-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-ene-4,8-diol

(1s,2r,3r,4s,5s,6s,8s,9s,10r,13r,16s,17r)-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-ene-4,8-diol

C21H31NO4 (361.2253)


   

5-[({[(3r,3as,6ar,8s,9ar,9bs)-8-hydroxy-6,9-dimethylidene-2-oxo-octahydro-3h-azuleno[4,5-b]furan-3-yl]methyl}amino)methyl]oxolan-2-one

5-[({[(3r,3as,6ar,8s,9ar,9bs)-8-hydroxy-6,9-dimethylidene-2-oxo-octahydro-3h-azuleno[4,5-b]furan-3-yl]methyl}amino)methyl]oxolan-2-one

C20H27NO5 (361.1889)


   

12-ethyl-9,17-dihydroxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.1²,⁶.0¹,¹¹.0³,⁹.0¹⁴,¹⁸]icosan-4-one

12-ethyl-9,17-dihydroxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.1²,⁶.0¹,¹¹.0³,⁹.0¹⁴,¹⁸]icosan-4-one

C21H31NO4 (361.2253)


   

2-[(1s,2s,4s,6r,7r,8r,10r,11r)-6,8-dihydroxy-4,7,11-trimethyl-5-methylidene-13-azatetracyclo[9.3.3.0¹,¹⁰.0²,⁷]heptadecan-13-yl]acetaldehyde

2-[(1s,2s,4s,6r,7r,8r,10r,11r)-6,8-dihydroxy-4,7,11-trimethyl-5-methylidene-13-azatetracyclo[9.3.3.0¹,¹⁰.0²,⁷]heptadecan-13-yl]acetaldehyde

C22H35NO3 (361.2617)


   

(2s,3r)-3-(acetyloxy)-1-[(1s,3r,10z)-8-methyl-2-oxa-6-azatricyclo[5.3.0.0¹,³]deca-6,8-dien-10-ylidene]butan-2-yl (2s)-2-methylbutanoate

(2s,3r)-3-(acetyloxy)-1-[(1s,3r,10z)-8-methyl-2-oxa-6-azatricyclo[5.3.0.0¹,³]deca-6,8-dien-10-ylidene]butan-2-yl (2s)-2-methylbutanoate

C20H27NO5 (361.1889)


   

14-ethyl-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10,12(21)-pentaene-10-carboxamide

14-ethyl-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10,12(21)-pentaene-10-carboxamide

C22H23N3O2 (361.179)


   

10-methoxy-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

10-methoxy-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

C24H27NO2 (361.2042)


   

(2z)-n-[2-(3-hydroxy-4-methoxyphenyl)ethyl]-3-methyldodec-2-enimidic acid

(2z)-n-[2-(3-hydroxy-4-methoxyphenyl)ethyl]-3-methyldodec-2-enimidic acid

C22H35NO3 (361.2617)


   

n-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-methyldodec-2-enimidic acid

n-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-methyldodec-2-enimidic acid

C22H35NO3 (361.2617)


   

5,7-dimethyl-7-azaspiro[hexacyclo[7.6.2.2¹⁰,¹³.0¹,⁸.0⁵,¹⁶.0¹⁰,¹⁵]nonadecane-12,2'-oxirane]-2,11,18-triol

5,7-dimethyl-7-azaspiro[hexacyclo[7.6.2.2¹⁰,¹³.0¹,⁸.0⁵,¹⁶.0¹⁰,¹⁵]nonadecane-12,2'-oxirane]-2,11,18-triol

C21H31NO4 (361.2253)


   

17-(hydroxymethyl)-9-methoxy-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7-diene-7,17-diol

17-(hydroxymethyl)-9-methoxy-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7-diene-7,17-diol

C21H31NO4 (361.2253)


   

(1r,2s,3s,5r,6r,8r,9s,11r,14s,16s,17s,18s,19r)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-2,3,6,18,19-pentol

(1r,2s,3s,5r,6r,8r,9s,11r,14s,16s,17s,18s,19r)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-2,3,6,18,19-pentol

C20H27NO5 (361.1889)


   

3-[1-(but-2-en-2-yl)-3-hydroxy-7-methyl-1,4,4a,5,8,8a-hexahydro-2-benzopyran-3-yl]-5-(2-methylpropyl)-4,5-dihydro-3h-pyrrol-2-ol

3-[1-(but-2-en-2-yl)-3-hydroxy-7-methyl-1,4,4a,5,8,8a-hexahydro-2-benzopyran-3-yl]-5-(2-methylpropyl)-4,5-dihydro-3h-pyrrol-2-ol

C22H35NO3 (361.2617)


   

(3r)-10-methoxy-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

(3r)-10-methoxy-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

C24H27NO2 (361.2042)


   

3-[hydroxy(1,2,6-trimethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalen-1-yl)methylidene]-5-(1-hydroxyethyl)-1-methylpyrrolidine-2,4-dione

3-[hydroxy(1,2,6-trimethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalen-1-yl)methylidene]-5-(1-hydroxyethyl)-1-methylpyrrolidine-2,4-dione

C21H31NO4 (361.2253)


   

5-(1-hydroxyethyl)-1-methyl-3-(1,2,6-trimethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalene-1-carbonyl)pyrrolidine-2,4-dione

5-(1-hydroxyethyl)-1-methyl-3-(1,2,6-trimethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalene-1-carbonyl)pyrrolidine-2,4-dione

C21H31NO4 (361.2253)


   

3-[(1s,2s,3r,7r,8s,10s,13s,14r)-7-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁸.0⁷,¹²]hexadecan-2-yl]propanoic acid

3-[(1s,2s,3r,7r,8s,10s,13s,14r)-7-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁸.0⁷,¹²]hexadecan-2-yl]propanoic acid

C22H35NO3 (361.2617)


   

(3r)-9-methoxy-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

(3r)-9-methoxy-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

C24H27NO2 (361.2042)


   

n-{5-[(2r,3r,4e,6z)-2,8-dihydroxy-7-[(1z)-prop-1-en-1-yl]octa-4,6-dien-3-yl]-4-hydroxy-2-methoxyphenyl}ethanimidic acid

n-{5-[(2r,3r,4e,6z)-2,8-dihydroxy-7-[(1z)-prop-1-en-1-yl]octa-4,6-dien-3-yl]-4-hydroxy-2-methoxyphenyl}ethanimidic acid

C20H27NO5 (361.1889)


   

(1s,8s,10r,17s)-4,5,6,8-tetramethoxy-16-methyl-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraene

(1s,8s,10r,17s)-4,5,6,8-tetramethoxy-16-methyl-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraene

C20H27NO5 (361.1889)


   

(13r)-13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,13-dihydroxytridecan-5-one

(13r)-13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,13-dihydroxytridecan-5-one

C18H35NO6 (361.2464)


   

(2s)-n-(5-carbamimidamido-1-oxopentan-2-yl)-2-[(1-hydroxypropylidene)amino]-3-phenylpropanimidic acid

(2s)-n-(5-carbamimidamido-1-oxopentan-2-yl)-2-[(1-hydroxypropylidene)amino]-3-phenylpropanimidic acid

C18H27N5O3 (361.2114)


   

10-methoxy-3,8-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

10-methoxy-3,8-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

C24H27NO2 (361.2042)


   

(3s)-10-methoxy-3,8-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

(3s)-10-methoxy-3,8-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

C24H27NO2 (361.2042)


   

13-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,13-dihydroxytridecan-5-one

13-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,13-dihydroxytridecan-5-one

C18H35NO6 (361.2464)


   

n-[2-(3-hydroxy-4-methoxyphenyl)ethyl]-3-methyldodec-2-enimidic acid

n-[2-(3-hydroxy-4-methoxyphenyl)ethyl]-3-methyldodec-2-enimidic acid

C22H35NO3 (361.2617)


   

2-methyl-3-(3,7,11-trimethyldodeca-2,4,6,10-tetraen-1-yl)-1h-quinolin-4-one

2-methyl-3-(3,7,11-trimethyldodeca-2,4,6,10-tetraen-1-yl)-1h-quinolin-4-one

C25H31NO (361.2406)


   

(2z)-n-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-methyldodec-2-enimidic acid

(2z)-n-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-methyldodec-2-enimidic acid

C22H35NO3 (361.2617)


   

(5s)-3-[(1s,2s,4ar,6s,8as)-1,2,6-trimethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalene-1-carbonyl]-5-[(1r)-1-hydroxyethyl]-1-methylpyrrolidine-2,4-dione

(5s)-3-[(1s,2s,4ar,6s,8as)-1,2,6-trimethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalene-1-carbonyl]-5-[(1r)-1-hydroxyethyl]-1-methylpyrrolidine-2,4-dione

C21H31NO4 (361.2253)


   

({[(3r,5r)-3-amino-6-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1,5-dihydroxyhexylidene]amino}(methyl)amino)acetic acid

({[(3r,5r)-3-amino-6-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1,5-dihydroxyhexylidene]amino}(methyl)amino)acetic acid

C15H31N5O5 (361.2325)


   

3-[(1s,2r,3s,7r,8r,10r,13r,14r)-3-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁸.0⁷,¹²]hexadecan-2-yl]propanoic acid

3-[(1s,2r,3s,7r,8r,10r,13r,14r)-3-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁸.0⁷,¹²]hexadecan-2-yl]propanoic acid

C22H35NO3 (361.2617)


   

3-[(1s,2r,3s,7r,8r,10r,13s,14r)-7-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁸.0⁷,¹²]hexadecan-2-yl]propanoic acid

3-[(1s,2r,3s,7r,8r,10r,13s,14r)-7-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁸.0⁷,¹²]hexadecan-2-yl]propanoic acid

C22H35NO3 (361.2617)


   

6-methoxy-8,16-dimethyl-19-(prop-1-en-2-yl)-15-oxa-4-azapentacyclo[14.3.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]icosa-2(14),3(11),5(10),6,8,12-hexaene

6-methoxy-8,16-dimethyl-19-(prop-1-en-2-yl)-15-oxa-4-azapentacyclo[14.3.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]icosa-2(14),3(11),5(10),6,8,12-hexaene

C24H27NO2 (361.2042)


   

4-ethyl-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosane-13,14,18-triol

4-ethyl-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosane-13,14,18-triol

C21H31NO4 (361.2253)


   

5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-2,3,6,18,19-pentol

5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-2,3,6,18,19-pentol

C20H27NO5 (361.1889)


   

(1s,2r,3s,6r,9s,10s,11r,14r,17s,18r)-12-ethyl-9,17-dihydroxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.1²,⁶.0¹,¹¹.0³,⁹.0¹⁴,¹⁸]icosan-4-one

(1s,2r,3s,6r,9s,10s,11r,14r,17s,18r)-12-ethyl-9,17-dihydroxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.1²,⁶.0¹,¹¹.0³,⁹.0¹⁴,¹⁸]icosan-4-one

C21H31NO4 (361.2253)


   

4,11,12-trimethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraene-3,13-diol

4,11,12-trimethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraene-3,13-diol

C20H27NO5 (361.1889)


   

(3r,5s)-3-[(1s,2s,4ar,6s,8as)-1,2,6-trimethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalene-1-carbonyl]-5-[(1r)-1-hydroxyethyl]-1-methylpyrrolidine-2,4-dione

(3r,5s)-3-[(1s,2s,4ar,6s,8as)-1,2,6-trimethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalene-1-carbonyl]-5-[(1r)-1-hydroxyethyl]-1-methylpyrrolidine-2,4-dione

C21H31NO4 (361.2253)


   

3-[(1s,2s,3s,7s,8r,10s,13s,14r)-3-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁸.0⁷,¹²]hexadecan-2-yl]propanoic acid

3-[(1s,2s,3s,7s,8r,10s,13s,14r)-3-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁸.0⁷,¹²]hexadecan-2-yl]propanoic acid

C22H35NO3 (361.2617)


   

(1s,2s,4s,6r,7r,8r,10r,11r)-13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecane-6,8-diol

(1s,2s,4s,6r,7r,8r,10r,11r)-13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecane-6,8-diol

C22H35NO3 (361.2617)


   

(13s)-13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,13-dihydroxytridecan-5-one

(13s)-13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,13-dihydroxytridecan-5-one

C18H35NO6 (361.2464)


   

3-[(2s,3r,7r,8s,13s,14r)-7-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁸.0⁷,¹²]hexadecan-2-yl]propanoic acid

3-[(2s,3r,7r,8s,13s,14r)-7-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁸.0⁷,¹²]hexadecan-2-yl]propanoic acid

C22H35NO3 (361.2617)


   

2-methyl-3-[(2e,4e,6e)-3,7,11-trimethyldodeca-2,4,6,10-tetraen-1-yl]-1h-quinolin-4-one

2-methyl-3-[(2e,4e,6e)-3,7,11-trimethyldodeca-2,4,6,10-tetraen-1-yl]-1h-quinolin-4-one

C25H31NO (361.2406)


   

(5r)-3-[(1r,2s,4as,6r,8ar)-1,2,6-trimethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalene-1-carbonyl]-4-hydroxy-5-[(1r)-1-hydroxyethyl]-1-methyl-5h-pyrrol-2-one

(5r)-3-[(1r,2s,4as,6r,8ar)-1,2,6-trimethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalene-1-carbonyl]-4-hydroxy-5-[(1r)-1-hydroxyethyl]-1-methyl-5h-pyrrol-2-one

C21H31NO4 (361.2253)


   

3-[(2s,3s,7s,8r,13s,14r)-3-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁸.0⁷,¹²]hexadecan-2-yl]propanoic acid

3-[(2s,3s,7s,8r,13s,14r)-3-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁸.0⁷,¹²]hexadecan-2-yl]propanoic acid

C22H35NO3 (361.2617)


   

1-hexahydro-1h-pyrrolizin-1-ylmethyl 4-methyl 2-benzyl-2-hydroxybutanedioate

1-hexahydro-1h-pyrrolizin-1-ylmethyl 4-methyl 2-benzyl-2-hydroxybutanedioate

C20H27NO5 (361.1889)


   

n-{5-[(2z,4r,5e,7r)-1,7-dihydroxy-2-[(1z)-prop-1-en-1-yl]octa-2,5-dien-4-yl]-4-hydroxy-2-methoxyphenyl}ethanimidic acid

n-{5-[(2z,4r,5e,7r)-1,7-dihydroxy-2-[(1z)-prop-1-en-1-yl]octa-2,5-dien-4-yl]-4-hydroxy-2-methoxyphenyl}ethanimidic acid

C20H27NO5 (361.1889)


   

(3r,5s)-3-[(1s,3r,4ar,8as)-1-[(2e)-but-2-en-2-yl]-3-hydroxy-7-methyl-1,4,4a,5,8,8a-hexahydro-2-benzopyran-3-yl]-5-(2-methylpropyl)-4,5-dihydro-3h-pyrrol-2-ol

(3r,5s)-3-[(1s,3r,4ar,8as)-1-[(2e)-but-2-en-2-yl]-3-hydroxy-7-methyl-1,4,4a,5,8,8a-hexahydro-2-benzopyran-3-yl]-5-(2-methylpropyl)-4,5-dihydro-3h-pyrrol-2-ol

C22H35NO3 (361.2617)


   

(1s,2r,4s,6r,7r,8r,10s,11r)-13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecane-6,8-diol

(1s,2r,4s,6r,7r,8r,10s,11r)-13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecane-6,8-diol

C22H35NO3 (361.2617)


   

(1s,10s,13s)-4,11,12-trimethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraene-3,13-diol

(1s,10s,13s)-4,11,12-trimethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraene-3,13-diol

C20H27NO5 (361.1889)